BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 33452586)

  • 1. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetuin-A and risk of diabetes-related vascular complications: a prospective study.
    Birukov A; Polemiti E; Jäger S; Stefan N; Schulze MB
    Cardiovasc Diabetol; 2022 Jan; 21(1):6. PubMed ID: 34998417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study.
    Huang ZG; Gao JW; Zhang HF; You S; Xiong ZC; Wu YB; Guo DC; Wang JF; Chen YX; Zhang SL; Liu PM
    Diabetes Obes Metab; 2024 Jul; 26(7):2673-2683. PubMed ID: 38558498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
    Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K;
    Cardiovasc Diabetol; 2018 Nov; 17(1):150. PubMed ID: 30486889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM study.
    Hayfron-Benjamin C; van den Born BJ; Maitland-van der Zee AH; Amoah AGB; Meeks KAC; Klipstein-Grobusch K; Bahendeka S; Spranger J; Danquah I; Mockenhaupt F; Beune E; Smeeth L; Agyemang C
    J Diabetes Complications; 2019 Aug; 33(8):572-578. PubMed ID: 31167710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
    Zhang X; Zhao S; Huang Y; Ma M; Li B; Li C; Zhu X; Xu X; Chen H; Zhang Y; Zhou C; Zheng Z
    J Am Heart Assoc; 2024 Jun; 13(11):e032626. PubMed ID: 38818935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Obesity and Microvascular Diseases in Patients With Type 2 Diabetes Mellitus.
    Gao S; Zhang H; Long C; Xing Z
    Front Endocrinol (Lausanne); 2021; 12():719515. PubMed ID: 34764938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; van Greevenbroek MMJ; de Jong M; Vos RC; Bots ML; Reulen JPH; Houben AJHM; Webers CAB; Berendschot TTJM; Dagnelie PC; Eussen SJPM; Schram MT; Koster A; Peters SAE; Stehouwer CDA
    Cardiovasc Diabetol; 2021 May; 20(1):102. PubMed ID: 33962619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes.
    Herrmann M; Sullivan DR; Veillard AS; McCorquodale T; Straub IR; Scott R; Laakso M; Topliss D; Jenkins AJ; Blankenberg S; Burton A; Keech AC;
    Diabetes Care; 2015 Mar; 38(3):521-8. PubMed ID: 25524951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the causal association of generalized and abdominal obesity with microvascular complications in patients with type 2 diabetes: A community-based prospective study.
    Chen J; Li YT; Niu Z; He Z; Xie YJ; Hernandez J; Huang W; Wang HHX;
    Diabetes Obes Metab; 2024 Jul; 26(7):2796-2810. PubMed ID: 38695216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes.
    Palladino R; Tabak AG; Khunti K; Valabhji J; Majeed A; Millett C; Vamos EP
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32332069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum BMI and microvascular complications in a cohort of Japanese patients with type 2 diabetes: the Japan Diabetes Complications Study.
    Tanaka S; Tanaka S; Iimuro S; Ishibashi S; Yamashita H; Moriya T; Katayama S; Akanuma Y; Ohashi Y; Yamada N; Araki A; Ito H; Sone H;
    J Diabetes Complications; 2016 Jul; 30(5):790-7. PubMed ID: 26997170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
    Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.
    Schienkiewitz A; Schulze MB; Hoffmann K; Kroke A; Boeing H
    Am J Clin Nutr; 2006 Aug; 84(2):427-33. PubMed ID: 16895894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin.
    Helliwell R; Warnes H; Kietsiriroje N; Campbell M; Birch R; Pearson SM; Ajjan RA
    Diabet Med; 2021 May; 38(5):e14529. PubMed ID: 33502032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes.
    Kaze AD; Santhanam P; Erqou S; Bertoni AG; Ahima RS; Echouffo-Tcheugui JB
    Diabetes Res Clin Pract; 2021 Jun; 176():108859. PubMed ID: 33989668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.